You searched for
We found 9 articles
FEV1 Lung Function Test

FEV1 Lung Function Test

Last updated: 12 December 2017

12 Dec 2017

Lung Function Tests

Lung Function Tests

Last updated: 8 December 2017

12 Aug 2017

Molecular mechanisms within foetal lungs that initiate labour

Molecular mechanisms within foetal lungs that initiate labour

Researchers at University of Texas Southwestern Medical Center have identified two proteins in a foetus’ lungs responsible for initiating the labour process, providing potential new…

17 Aug 2015

Aussies missing vital treatments for killer lung disease

Aussies missing vital treatments for killer lung disease

Thousands of Australians with the chronic lung disease COPD may be missing out of some of the most effective non-drug…

22 Nov 2013

Lume Lung 2: BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

The trial will be performed to evaluate if BIBF 1120 in combination with standard pemetrexed therapy is more effective than placebo plus standard pemetrexed therapy…

01 Jan 2013

Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer

Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer

Rationale: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxytol, may help find and diagnose primary brain cancer or brain…

01 Jan 2013

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

The purpose of this study is to determine if OSI-774 will improve overall survival of patients with incurable stage IIIB/IV…

01 Jan 2013

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

This study is a Phase 3, global, multi-center, open-label study of patients with extensive-stage small cell lung cancer. Eligible patients…

01 Jan 2013

BUILD 3: Bosentan Use in Interstitial Lung Disease

BUILD 3: Bosentan Use in Interstitial Lung Disease

BUILD 3 is a prospective, multicenter, randomized, double-blind, parallel group, placebo-controlled, event-driven, group sequential, phase III superiority study. The primary…

01 Jan 2013